The puropse of this non-interventional register and survey study is to identify the patterns of prescribed pain, anti-depressive and anti-anxiety medication and management of pain, depression and anxiety for people with haemophilia. The study will be conducted in the Nordic countries (Sweden, Norway, Denmark, Finland) and the aim is to cover the entire haemophilia population in the register part of the study.
Study Type
OBSERVATIONAL
Enrollment
2,300
Swedish Orphan Biovitrum Research Site
Copenhagen, Denmark
Swedish Orphan Biovitrum Research Site
Helsinki, Finland
Swedish Orphan Biovitrum Research Site
Gothenburg, Sweden
Swedish Orphan Biovitrum Research Site
Malmö, Sweden
Use of medication for pain, depression and anxiety (yes/no?)
Based on Registry data
Time frame: Retrospectively 10 years
Annualised consumption of pain medications as assessed by filled prescription
Based on Registry data
Time frame: Retrospectively 10 years
Annualised consumption of anti-anxiety medications as assessed by filled prescription
Based on Registry data
Time frame: Retrospectively 10 years
Annualised consumption of anti-depressive medications as assessed by filled prescription
Based on Registry data
Time frame: Retrospectively 10 years
Duration of pain medications as measured by expected doses of medicines.
Based on Registry data
Time frame: Retrospectively 10 years
Duration of anti-depressive medications as measured by expected doses of medicines.
Based on Registry data
Time frame: Retrospectively 10 years
Duration of anti-anxiety medications as measured by expected doses of medicines.
Based on Registry data
Time frame: Retrospectively 10 years
Pharmacological and non-pharmacological treatments for management of Health-Related Quality of Life (HRQoL) impairment, including treatment of pain
Assessed by Health Care Professional (HCP) survey in Part B1
Time frame: Inclusion in survey study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Swedish Orphan Biovitrum Research Site
Stockholm, Sweden
Pharmacological and non-pharmacological treatments for management of HRQoL impairment, including treatment of anxiety
Assessed by HCP survey in Part B1
Time frame: Inclusion in survey study
Pharmacological and non-pharmacological treatments for management of HRQoL impairment, including treatment of depression
Assessed by HCP survey in Part B1
Time frame: Inclusion in survey study
The perspective and experience of HCPs with direct and frequent patient Contacts on the strategies for the management of HRQoL impairment, including treatment of pain at each Haemophlia Treatment Centre
Assessed by HCP survey in Part B1
Time frame: Inclusion in survey study
The perspective and experience of HCPs with direct and frequent patient Contacts on the strategies for the management of HRQoL impairment, including treatment of anxiety at each Haemophlia Treatment Centre
Assessed by HCP survey in Part B1
Time frame: Inclusion in survey study
The perspective and experience of HCPs with direct and frequent patient Contacts on the strategies for the management of HRQoL impairment, including treatment of depression at each Haemophlia Treatment Centre
Assessed by HCP survey in Part B1
Time frame: Inclusion in survey study
Self-reported current and previous use of medications for pain
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Self-reported current and previous use of medications for anxiety
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Self-reported current and previous use of medications for depression
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Social and physical activity level
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Euro-QoL 5 Dimensions 5 Levels (EQ-5D-5L)
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Patient satisfaction with current management of pain
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Patient satisfaction with current management anxiety
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Patient satisfaction with current management of depression
Assessed by patient survey in Part B2
Time frame: Inclusion in survey study
Patient satisfaction of received treatment for pain
Assessed by patient survey in Part B2
Time frame: Inclusion in Survey study
Patient satisfaction of received treatment for anxiety
Assessed by patient survey in Part B2
Time frame: Inclusion in Survey study
Patient satisfaction of received treatment for depression
Assessed by patient survey in Part B2
Time frame: Inclusion in Survey study